Avelumab in Men With Metastatic Castration-Resistant Prostate Cancer, Enriched for Patients Treated Previously With a Therapeutic Cancer Vaccine

Therapeutic cancer vaccines including sipuleucel-T, a prostatic acid phosphatase (PAP) targeted vaccine that improves survival in metastatic castration-resistant prostate cancer (mCRPC), can produce immune responses that translate to clinical benefit. The effects of sequential checkpoint inhibitors...

Descripción completa

Detalles Bibliográficos
Autores principales: Madan, Ravi A., Redman, Jason M., Karzai, Fatima, Dahut, William L., Cordes, Lisa, Fakhrejahani, Farhad, Vu, Tuyen, Sheikh, Nadeem, Schlom, Jeffrey, Gulley, James L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2023
Materias:
Clinical Studies
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10072211/
https://www.ncbi.nlm.nih.gov/pubmed/36821354
http://dx.doi.org/10.1097/CJI.0000000000000459

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10072211/
https://www.ncbi.nlm.nih.gov/pubmed/36821354
http://dx.doi.org/10.1097/CJI.0000000000000459

Ejemplares similares